|
| PFS* | 95% CI | P value | 0S* | 95% CI | p value |
| Age |
|
| 0.06 |
|
| 0.35 |
| <60 | Not reached |
| Not reached |
| ||
| ≥60 | 37.77 | 34.20 - 41.34 |
| 43.81 | 43.76 - 43.87 |
|
| Pathological type |
|
| 0.08 |
|
| 0.94 |
| endometrioid | 38.80 |
|
| Not reached |
| |
| Serous and clear | 37.77 | 31.72 - 43.82 |
| 43.78 | 23.28 - 64.29 |
|
| Pathological grade |
|
| 0.05 |
|
| 0.53 |
| I & II | Not reached |
| Not reached |
| ||
| III | Not reached |
| 45.13 | 42.53 - 47.73 |
| |
| Myometrial infiltration |
|
| 0.58 |
|
| 0.15 |
| <50% | 38.45 | 37.47 - 39.44 |
| Not reached |
| |
| ≥50 | 37.74 | 28.18 - 47.29 |
| 43.82 | 23.1 - 64.48 |
|
| lV infiltration |
|
| 0.01 |
|
| 0.09 |
| Present | 37.74 | 34.37 - 41.11 |
| 43.81 | 43.75 - 43.88 |
|
| Absent | Not reached |
| Not reached |
| ||
| Risk stratification |
|
| 0.02 |
|
| 0.09 |
| Intermediate risk | Not reached |
| Not reached |
| ||
| High risk | 37.74 | 34.37 - 41.11 |
| 43.82 | 43.75 - 43.88 |
|
| lymphadenectomy |
|
| 0.35 |
|
| 0.69 |
| done | 38.06 | 34.14 - 41.98 |
| 43.78 | 23.22 - 64.34 |
|
| Not done | 38 | 36.11 - 41.48 |
| Not reached |
| |